Pediatric blood & cancer
-
Pediatric blood & cancer · Aug 2019
Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunities.
It is well appreciated that the number of anticancer drugs approved for use in children is a fraction of the number approved for use in cancers that occur in adults. We address this fact by summarizing the relevant U. ⋯ In total, the Food and Drug Administration (FDA) has approved 38 new drug applications for pediatric oncology indications, 12 of which were new molecular entities. FDA continues to collaborate with multistakeholders regarding the development of products intended for pediatric cancer and encourages the submission of marketing applications.